No recommendation
No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.
(Sharecast News) - London-listed BlackRock Income & Growth Investment Trust has reiterated its constructive long-term view of the UK market in face of ongoing macro volatility, as it reported an improvement in its portfolio value over the past month.
The trust, which mainly invests in UK-listed shares, reported a net asset value return of 1.5% for the month of June, resulting in a 4.5% improvement over the April-June period and a 13.8% increase over one year.
The portfolio was valued at 53.3m by 30 June, equating to a net asset value of 254.25p per share.
At the end of June, the top sectors it was invested in were banks (15.2% of total assets), pharma and biotech (10.8%), oil and gas producers and general retailers (both 5.9%).
AstraZeneca was the trust's largest holding, at 8.5% of the fund, followed by HSBC (5.9%) and British American Tobacco (5.1%).
Bright highlighted two stocks that helpd to drive its returns growth during the period, Next (3.0% of assets) and Lloyds (4.7%), while defence contractor Babcock detracted from relative returns due to political uncertainty and uncertainty surrounding the UK's Defence Investment.
BRIG shares were up 0.8% at 228.7p by 1600 BST.
The value of investments can go down in value as well as up, so you could get back less than you invest. It is therefore important that you understand the risks and commitments. This website is not personal advice based on your circumstances. So you can make informed decisions for yourself we aim to provide you with the best information, best service and best prices. If you are unsure about the suitability of an investment please contact us for advice.